Toxicity assessment of aggregated/agglomerated cerium oxide nanoparticles in an in vitro 3D airway model: The influence of mucociliary clearance

Toxicology in Vitro

Volumn 29, Issue 2, 2015, Pages 389-397

  Frieke Kuper, C ^a   Gröllers Mulderij, Mariska ^a   Maarschalkerweerd, Thérèse ^a   Meulendijks, Nicole M M ^a   Reus, Astrid ^a   van Acker, Frédérique ^a   Zondervan van den Beuken, Esther K ^a   Wouters, Mariëlle E L ^a   Bijlsma, Sabina ^a   Kooter, Ingeborg M ^a  

^a TNO   (Netherlands)

Author keywords

Cerium oxide; In vitro 3D human bronchial epithelial model; Mucociliary apparatus; Mucociliary clearance

Indexed keywords

CERIC OXIDE; CERIUM; CYTOKINE; HEME OXYGENASE 1; HMOX1 PROTEIN, HUMAN; METAL NANOPARTICLE;

BIOLOGICAL MODEL; BRONCHUS; CELL CULTURE; COMET ASSAY; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MUCOCILIARY CLEARANCE; MUCUS; TUMOR CELL LINE;

BRONCHI; CELL LINE, TUMOR; CELLS, CULTURED; CERIUM; COMET ASSAY; CYTOKINES; HEME OXYGENASE-1; HUMANS; METAL NANOPARTICLES; MODELS, BIOLOGICAL; MUCOCILIARY CLEARANCE; MUCUS;

EID: 84920082577     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.10.017     Document Type: Article

References (29)

1. Brooking J., Davis S.S., Illum L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target 2001, 9:267-279. 10.3109/10611860108997935.
2. Cassee F.R., van Balen E.C., Singh C., Green D., Muijser H., Weinstein J., Dreher K. Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit. Rev. Toxicol. 2011, 41:213-229. 10.3109/10408444.2010.529105.
3. Cho W.-S., Duffin R., Bradley M., Megson I.L., MacNee W., Lee J.K., Jeong J., Donaldson K. Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part. Fibre Toxicol. 2013, 10:55. 10.1186/1743-8977-10-55.
4. Gilbert B., Fakra S.C., Xia T., Pokhrel S., Madler L., Nel A.E. The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS Nano 2012, 6:4921-4930. 10.1021/nn300425a.
5. Gosens I., Mathijssen L.E., Bokkers B.G., Muijser H., Cassee F.R. Comparative hazard identification of nano- and micro-sized cerium oxide particles based on 28-day inhalation studies in rats. Nanotoxicology 2014, 8:643-653. 10.3109/17435390.2013.815814.
6. Gradon L., Sosnowski T.R. Formation of particles for dry powder inhalers. Adv. Powder Technol. 2014, 25:43-55. 10.1016/j.apt.2013.09.012.
7. Grellet S., Momas I., Seta N., Bardet G., Achard S. Reconstituted human airway epithelium 3D-model to assess the impact of indoor air pollutants on the inflammatory response. Toxicol. Lett. 2013, 221:S112. 10.1016/j.toxlet.2013.05.184.
8. Hackenberg S., Scherzed A., Technau A., Kessler M., Froehlich K., Ginzkey C., Koelher C., Burghartz M., Hagen R., Kleinsasser N. Cytotoxic, genotoxic and pro-inflammatory effects of zinc oxide nanoparticles in human nasal mucosa cell in vitro. Toxicol. In Vitro 2011, 25:657-663. 10.1016/j.tiv.2011.01.003.
9. Henning A., Schneider M., Nafee N., Muijs L., Rytting E., Wang X., Kissel T., Grafahrend D., Klee D., Lehr C.-M. Influence of particle size and material properties on mucociliary clearance from the airways. J. Aerosol Med. Pulm. Drug Deliv. 2010, 23:233-241. 10.1089/jamp.2009.0806.
10. Huang, S., Constant, S., Wisniewski, L., Derouette, J.P., 2008. MucilAir: a novel human 3D airway epithelium model for acute or long term toxicity testing of chemicals. ALTEX 25 (Suppl. 1), 30-31 http://www.altex.ch/resources/Huang.pdf.
11. Huang S., Wisniewski L., Constant S. The use of in vitro 3D cell models in drug development for respiratory diseases. Drug Discovery and Development - Present and Future 2011, InTech - Open Access Company, pp. 169-190, http://dx.doi.org/10.5772/28132. I.M. Kapetanovic (Ed.).
12. Huang S., Wisniewskia L., Constant S., Roggen E. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir™) to assess respiratory sensitizers. Toxicol. In Vitro 2013, 27:1151-1156. 10.1016/j.tiv.2012.10.010.
13. Kirch J., Guenther M., Doshi N., Schaefer U.F., Schneider M., Mitragotri S., Lehr C.-M. Mucociliary clearance of micro- and nanoparticles is independent of size, shape and charge - an ex vivo and in silico approach. J. Control Release 2012, 159:128-134. 10.1016/j.jconrel.2011.12.015.
14. Landsiedel R., Ma-Hock L., Hofmann T., Wiemann M., Strauss V., Treumann S., Wohlleben W., Gröters S., Wiench K., van Ravenzwaay B. Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part. Fibre Toxicol. 2014, 11:1-26.
15. Limbach L.K., Li Y., Grass R.N., Brunner T.J., Hintermann M.A., Muller M., Gunther D., Stark W.J. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 2005, 39:9370-9376. 10.1021/es051043o.
16. Lippmann M., Yeates D.B., Albert R.E. Deposition, retention, and clearance of inhaled particles. Br. J. Ind. Med. 1980, 37:337-362.
17. Mura S., Hillaireau H., Nicolas J., Kerdine-Römer S., Le Droumaguet B., Deloménie C., Nicolas V., Pallardy M., Tsapis N., Fattal E. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules 2011, 12:4136-4143. 10.1021/bm201226x.
18. Murray E.P., Tsai T., Barnett S.A. A direct methane fuel cell with ceria based a node. Nature 1999, 400:649-651.
19. Nahar K., Gupta N., Gauvin R., Absar S., Patel B., Gupta V., Khademhosseini A., Ahsan F. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur. J. Pharm. Sci. 2013, 49:805-818. 10.1016/j.ejps.2013.06.004.
20. Nichols J.E., Niles J.A., Vega S., Cortiella J. Novel in vitro respiratory models to study lung development, physiology, pathology and toxicology. Stem Cell Res. Ther. 2013, 4(Suppl. 1):S7. 10.1186/scrt368.
21. Oberdörster G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup Envrion. Health 2001, 74:1-8. 10.1007/s004200000185.
22. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839. 10.1289/ehp.7339.
23. OECD Guidelines for the Testing of Chemicals, Section 4. Test No. 412: Subacute Inhalation Toxicity: 28-Day Study, doi:10.1787/9789264070783-en.
24. Randell S.H., Fulcher M.L., O'Neal W., Olsen J.C. Primary epithelial cell models for cystic fibrosis research. Methods Mol. Biol. 2011, 742:285-310. 10.1007/978-1-61779-120-8_18.
25. Sauer U., Vogel S., Hess A., Kolle S.N., Ma-Hock L., van Ravenzwaay B., Landsiedel R. In vivo-in vitro comparison of acute respiratory tract toxicity using human 3D airway epithelial models and human A549 and murine 3T3 monolayer cell systems. Toxicol. In Vitro 2013, 27:174-190. 10.1016/j.tiv.2012.10.007.
26. U.S. Environmental Protection Agency, Washington DC, 2009. Toxicological review of Cerium oxide and Cerium compounds. In support of summary information on the integrated risk information system (IRIS). http://www.epa.gov/iris/toxreviews/1018tr.pdf.
27. Vandebriel R.J., de Jong W.H. A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol. Sci. Appl. 2012, 5:61-71. 10.2147/NSA.S23932.
28. Xia T., Kovochich M., Liong M., Madlers L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134. 10.1012/nn800511k.
29. Zheng X., Zhang X., Wang X., Wang S., Wu S. Preparation and characterization of Cu/CeO2 catalysts and their applications in low-temperature CO oxidation. Appl. Catal. A: Gen. 2005, 295:142-149.